The estimated Net Worth of Adam Muzikant is at least $1.01 Million dollars as of 19 July 2021. Adam Muzikant owns over 1,870 units of Flexion Therapeutics Inc stock worth over $952,691 and over the last 4 years Adam sold FLXN stock worth over $56,637.
Adam has made over 2 trades of the Flexion Therapeutics Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently Adam sold 1,870 units of FLXN stock worth $12,062 on 19 July 2021.
The largest trade Adam's ever made was selling 4,005 units of Flexion Therapeutics Inc stock on 5 January 2021 worth over $44,576. On average, Adam trades about 1,175 units every 39 days since 2021. As of 19 July 2021 Adam still owns at least 103,666 units of Flexion Therapeutics Inc stock.
You can see the complete history of Adam Muzikant stock trades at the bottom of the page.
Adam's mailing address filed with the SEC is C/O FLEXION THERAPEUTICS, INC., 10 MALL ROAD, SUITE 301, BURLINGTON, MA, 01803.
Over the last 11 years, insiders at Flexion Therapeutics Inc have traded over $7,066,621 worth of Flexion Therapeutics Inc stock and bought 7,091,809 units worth $98,920,816 . The most active insiders traders include Holdings A/S Novo, Bradley J Ph D Bolzon, and Samuel D Colella. On average, Flexion Therapeutics Inc executives and independent directors trade stock every 24 days with the average trade being worth of $609,564. The most recent stock trade was executed by Christina Willwerth on 19 July 2021, trading 3,945 units of FLXN stock currently worth $25,445.
Flexion Therapeutics is a biopharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of people with musculoskeletal conditions, beginning with osteoarthritis, the most common form of arthritis. The Company's core values are focus, ingenuity, tenacity, transparency and fun.
Flexion Therapeutics Inc executives and other stock owners filed with the SEC include: